12. Women of childbearing potential and men with partners of childbearing potential must agree to use a method of contraception that is acceptable to their physicians from time of first signing the informed consent until at least 12 weeks after the end of study drug administration. If a woman becomes pregnant or suspects she is pregnant while participating in this study, she must agree to inform her treating physician immediately.